SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-045470
Filing Date
2011-08-11
Accepted
2011-08-11 07:39:39
Documents
1
Period of Report
2011-08-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v231626_4.html 4  
1 OWNERSHIP DOCUMENT v231626_4.xml 4 3971
  Complete submission text file 0001144204-11-045470.txt   5246
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Fowler Wyche JR (Reporting) CIK: 0001381064 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 111025932